Research location
Genova
Italy, Italy
Advertisement
Research activity in Genova
Italy, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Genova
8 linked trials · page 1 of 1Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.NCT06364267 · 2025-10-01 · 1 site observation
RECRUITING
PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)NCT07089550 · 2025-04-02 · 1 site observation
RECRUITING
Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple SclerosisNCT07114809 · 2024-09-02 · 3 site observations
RECRUITING
Improving Hand Movement and Coordination in People With Multiple Sclerosis Using Transcranial Magnetic Stimulation (TMS) and Muscle Electrostimulation (FES) To Support Manual Dexterity and Daily FunctionNCT07098273 · 2025-10-01 · 1 site observation
NOT_YET_RECRUITING
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active TreatmentNCT04932863 · 2021-03-15 · 1 site observation
COMPLETED
Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With AsthmaNCT02892344 · 2017-01-16 · 1 site observation
COMPLETED
Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.NCT06601205 · 2004-01-01 · 1 site observation
COMPLETED
Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast NeoplasmsNCT06982313 · 1996-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.